Japan Recommends Mitsubishi Tanabe’s Canagliflozin
This article was originally published in PharmAsia News
Executive Summary
The First Committee of Japan’s Pharmaceutical Affairs and Food Safety Council on April 25 recommended for approval Mitsubishi Tanabe’s Canaglu 100 mg tablets (canagliflozin hydrate) for the treatment of type 2 diabetes.